PATENT CLAIM ANALYSIS

Application Number: 16018292
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["424", "186100"]

Abstract:
The present invention provides an immunogenic influenza composition in a dose volume suitable for human use, comprising an influenza virus antigen or antigenic preparation thereof and an adjuvant composition comprising an oil-in-water emulsion, wherein said oil-in-water emulsion comprises a metabolisable oil at a level of below 11 mg and an emulsifying agent at a level of below 5 mg and optionally a tocol or a sterol at a level of below 12 mg. Suitably the amount of influenza antigen per strain per dose is 15 μg HA or a low amount such as less than 15 μg HA.

Claim (Index 16):
The immunogenic composition of  claim 13 , wherein the influenza virus antigen or antigenic preparation thereof is from influenza virus grown in cell culture and wherein the antigen or antigenic preparation thereof is depleted from host cell contaminants.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 94.0
- Lexical Diversity: 1.62903
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15446508', '12596202', '12103136', '13163002', '14996446']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8817486169433147
- 35 USC 102 Novelty (BERT): 0.793731229120432
- Combined Prediction Score: 0.8729468781610266
- Mean Citation Score: 897.083582
- Max Citation Score: 1025.0135
- Similarity Product: 984.913303355217

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test